These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 8861784)
1. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes. Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784 [TBL] [Abstract][Full Text] [Related]
2. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365 [TBL] [Abstract][Full Text] [Related]
3. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol. Horinouchi T; Koike K J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363 [TBL] [Abstract][Full Text] [Related]
4. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727 [TBL] [Abstract][Full Text] [Related]
5. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819 [TBL] [Abstract][Full Text] [Related]
6. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells. Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164 [TBL] [Abstract][Full Text] [Related]
7. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530 [TBL] [Abstract][Full Text] [Related]
8. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor. Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793 [TBL] [Abstract][Full Text] [Related]
9. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Kaumann AJ; Molenaar P Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor subtype expression and function in rat white adipocytes. Germack R; Starzec AB; Vassy R; Perret GY Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110 [TBL] [Abstract][Full Text] [Related]
11. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105 [TBL] [Abstract][Full Text] [Related]
12. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines. Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220 [TBL] [Abstract][Full Text] [Related]
13. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Hoffstedt J; Lönnqvist F; Shimizu M; Blaak E; Arner P Int J Obes Relat Metab Disord; 1996 May; 20(5):428-34. PubMed ID: 8696421 [TBL] [Abstract][Full Text] [Related]
14. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106 [TBL] [Abstract][Full Text] [Related]
15. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes. Hollenga C; Zaagsma J Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a functional beta 3-adrenoceptor in man. Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344 [TBL] [Abstract][Full Text] [Related]
17. Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice. Oostendorp J; Preitner F; Moffatt J; Jimenez M; Giacobino JP; Molenaar P; Kaumann AJ Br J Pharmacol; 2000 Jun; 130(4):747-58. PubMed ID: 10864880 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol. Horinouchi T; Koike K Pharmacology; 1999 Dec; 59(6):290-7. PubMed ID: 10575323 [TBL] [Abstract][Full Text] [Related]
19. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat. Malinowska B; Schlicker E Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of an in vivo functional beta 3-adrenoceptor in man. Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]